US equities
|
MU
$1,069.16
▼-1.73%
NVDA
$234.81
▼-1.12%
SNDK
$1,640.58
▼-3.06%
PLTR
$198.06
▲+2.03%
AMD
$632.45
▼-2.08%
INTC
$109.28
▼-3.39%
SPCX
$163.19
▼-2.63%
META
$718.66
▼-0.37%
MU
$1,069.16
▼-1.73%
NVDA
$234.81
▼-1.12%
SNDK
$1,640.58
▼-3.06%
PLTR
$198.06
▲+2.03%
AMD
$632.45
▼-2.08%
INTC
$109.28
▼-3.39%
SPCX
$163.19
▼-2.63%
META
$718.66
▼-0.37%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about NASDAQ:VRDN
Recent news which mentions NASDAQ:VRDN
VRDN Stock Earnings: Viridian Therapeutics Misses EPS, Misses Revenue for Q2 2024
August 08, 2024
Tickers
VRDN
Tags
Earnings Reports
Market News
NASDAQ:VRDN
From
InvestorPlace
VRDN Stock Earnings: Viridian Therapeutics Beats EPS, Beats Revenue for Q1 2024
May 08, 2024
Tickers
VRDN
Tags
Earnings Reports
VRDN
NASDAQ:VRDN
From
InvestorPlace
Viridian Therapeutics (VRDN) Stock Jumps 60% on Promising Clinical Trial
August 15, 2022
Tickers
VRDN
Tags
VRDN
NASDAQ:VRDN
Market News
From
InvestorPlace